Anatumomab mafenatox, CAS 1370261-50-9

Product Description: Anatumomab mafenatox (ABR-214936) is a 73 KDa recombinant protein to recognize the tumor-associated antigen 5T4, which is widely expressing in malignancy. Anatumomab mafenatox is between a modified form of SEA and a murine Fab. The main side effects of Anatumomab mafenatox are reported to include fever, low blood pressure, pain, nausea and drowsiness[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Shaw DM, et al. A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma. Br J Cancer. 2007 Feb 26;96(4):567-74.

CAS Number: 1370261-50-9

Molecular Weight: N/A

Research Area: Cancer; Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Others

• SKU: MEXHY-P99436-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99436-5
• Green Labware: No
• Package Unit: 5mg
• Quantity Unit: STK